Angiotensin‐converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin‐converting enzyme 2 in patients with cardiovascular disease

AIMS: Coronavirus disease 2019 (COVID‐19) is a widespread pandemic with an increased morbidity and mortality, especially for patients with cardiovascular diseases. Angiotensin‐converting enzyme 2 (ACE2) has been identified as necessary cell entry point for SARS‐CoV‐2. Previous animal studies have de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Heart Fail
Main Authors: Lebek, Simon, Tafelmeier, Maria, Messmann, Rebecca, Provaznik, Zdenek, Schmid, Christof, Maier, Lars S., Birner, Christoph, Arzt, Michael, Wagner, Stefan
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd. 2020
Assuntos:
Covid‐19
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7675329/
https://ncbi.nlm.nih.gov/pubmed/33017071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.2020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados